Published: June 2024

Last updated: October 2025

‘Progress Is Impossible Without Change’… A Case Study To Feasibly Incorporate Environmental Sustainability In Health Technology Assessment

INTRODUCTION: Environmental sustainability and its incorporation in health technology assessment (HTA) is becoming increasingly researched globally. However, this has yet to lead to a significant impact on HTA processes. This research presents a novel case study, demonstrating how available methods can deepen the understanding of evidence-based approaches to healthcare decision making and support HTA sustainability policy development.

METHODS: A decision analytic model was developed for a digital health technology used to support primary care in the diagnosis and triage of musculoskeletal conditions. The model mapped the potential impact on the care pathway, capturing differences in resource use, including appointments, medications, diagnostic tests, surgical procedures and other non-pharmacological treatments. The model was populated from a UK perspective and captured both health-economic impact and carbon dioxide equivalents CO2e impact. Additional potential environmental impacts were then considered qualitatively as part of the evaluation.

RESULTS: The health economic modelling approach captures all stages of the patient care pathway and resource use demonstrating its practicality for simultaneously mapping out the carbon impacts. This methodological approach is reproducible, transparent and provides a standardised tool for use in future carbon, cost-comparison modelling. This would present decision makers with more complete information. There are some limitations to this approach, such as ambiguity regarding some carbon data estimates used, but still provides a more useful summary than no estimated quantification.

CONCLUSIONS: Adapting HTA will support wider efforts in health systems to reduce environmental impacts. This model can be practically applied to account for both cost and carbon data, facilitating a holistic and environmentally sustainable approach to decision making. As part of encouraging additional research into the environment, HTA agencies will need to provide ‘incentives’ for companies to undertake this additional research.

You may also be interested in

Peer-reviewed publication

Reducing Opioid Use for Chronic Pain With a Group-Based Intervention: Economic Evaluation using Randomised Controlled Trial Data

YHEC authors: Joe Moss
Publication date: October 2026
Journal: Addiction

Abstract

BACKGROUND AND AIMS: Long-term strong opioid use for chronic non-malignant pain (CNMP) represents a significant public health challenge, associated with reduced health-related quality of life (HRQoL) and increased mortality. The...

Peer-reviewed publication

Methods in Systematic Reviews of Health Economic Evaluations in Submissions to Health Technology Assessment Agencies: How Systematic Are They, and Does This Matter?

YHEC authors: Chris Bartlett, Rachael McCool, Matthew Taylor
Publication date: October 2026
Journal: PharmacoEconomics

Abstract

Systematic reviews of health economic evaluations (SR-HEEs) are perceived as mandatory components of the health technology assessment (HTA) process in many jurisdictions. However, HTA agencies vary in how they prescribe...

Peer-reviewed publication

Commentary: Selpercatinib versus Multi-Kinase Inhibitors for Advanced Medullary Thyroid Cancer: A Network Meta-Analysis of RET-Targeted Therapies

YHEC authors: Joe Moss, Erin Barker
Publication date: October 2026
Journal: Frontiers in Endocrinology

Abstract

We have read with great interest the published network meta-analysis (NMA) by Wang et al. (2026) in Frontiers in Endocrinology, which synthesised available randomised controlled trial (RCT) evidence to evaluate...